KALA - Kala Pharmaceuticals EPS misses by $0.01 beats on revenue August, 06 2020 07:08 AM Kala Pharmaceuticals Inc. Kala Pharmaceuticals (NASDAQ:KALA): Q2 GAAP EPS of -$0.42 misses by $0.01.More news on: Kala Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...